4.7 Article

Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Subgroup analysis of clinical and MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study

Bruce A. C. Cree et al.

Summary: The study found that cladribine tablets significantly reduced the risk of conversion to multiple sclerosis and lesion burden in participants with a first clinical demyelinating event in both the overall intent-to-treat population and various subgroups defined by baseline demographics and lesion characteristics. This reduction in risk was consistent across different baseline characteristics.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)

Review Neurosciences

Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis

Maria Petracca et al.

Summary: This article provides an up-to-date overview of structural, functional, and metabolic correlates of cognitive impairment in adults with MS, with a focus on the mechanisms sustaining damage accrual and on the identification of useful imaging markers of cognitive decline.

BRAIN SCIENCES (2021)

Article Clinical Neurology

Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis

Eleonora Virgilio et al.

Summary: CSF Tau levels may predict early disability accumulation in Multiple Sclerosis patients. Other predictors of disability include spinal cord involvement, age at MS diagnosis, and high brain lesion load.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)

Article Clinical Neurology

Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study

Natasa Giedraitiene et al.

Summary: This study found that over a 5-year follow-up, patients with multiple sclerosis experienced significant declines in information processing speed, visual learning, temporal RNFL thickness, the Huckman index, and third ventricle mean diameter. Presence of OCBs and atrophy of certain brain areas were significantly related to cognitive decline in these patients, suggesting their potential utility as biomarkers for cognitive impairment in MS.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

The Expanded Disability Status Scale Score and Demographic Indexes Are Correlated with the Severity of Cognitive Impairment in Multiple Sclerosis Patients

Saeed Sadigh-Eteghad et al.

Summary: This study found that information processing speed and working memory were the most affected cognitive domains in multiple sclerosis patients. The severity of cognitive impairment was positively correlated with current age, EDSS score, and disease duration, and negatively correlated with education level, while age at disease onset and relapse rate were not correlated with cognitive impairment severity.

JOURNAL OF CLINICAL NEUROLOGY (2021)

Review Cell Biology

Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers

Lorenzo Gaetani et al.

Summary: Cognitive impairment is a common clinical manifestation of multiple sclerosis, and studies have shown that biomarkers in the cerebrospinal fluid may be correlated with cognitive deficits in MS. Different pathophysiological mechanisms seem to be reflected by different cerebrospinal fluid biomarkers, providing insights into the specific cognitive domains affected by MS.

NEURAL REGENERATION RESEARCH (2021)

Article Clinical Neurology

Serum neurofilament light chain No clear relation to cognition and neuropsychiatric symptoms in stable MS

Orhan Aktas et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Article Multidisciplinary Sciences

Intrathecal kappa free light chains as markers for multiple sclerosis

D. Vecchio et al.

SCIENTIFIC REPORTS (2020)

Article Clinical Neurology

The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 years

Lucie Friedova et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Article Medicine, Research & Experimental

Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis?

Thaleia Kalatha et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2019)

Article Clinical Neurology

Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis

Lorenzo Gaetani et al.

JOURNAL OF NEUROLOGY (2019)

Article Clinical Neurology

Kappa free light chains could predict early disease course in multiple sclerosis

D. Vecchio et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)

Review Neurosciences

Multiple sclerosis and cognition: synaptic failure and network dysfunction

Massimiliano Di Filippo et al.

NATURE REVIEWS NEUROSCIENCE (2018)

Article Clinical Neurology

Recommendations for cognitive screening and management in multiple sclerosis care

Rosalind Kalb et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Article Clinical Neurology

Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis

R. Sacco et al.

EUROPEAN JOURNAL OF NEUROLOGY (2016)

Article Clinical Neurology

Tau protein: a possible prognostic factor in optic neuritis and multiple sclerosis

J. Frederiksen et al.

MULTIPLE SCLEROSIS JOURNAL (2012)

Article Clinical Neurology

Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria

Chris H. Polman et al.

ANNALS OF NEUROLOGY (2011)

Article Clinical Neurology

Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis

FJ Jiménez-Jiménez et al.

ACTA NEUROLOGICA SCANDINAVICA (2002)

Article Clinical Neurology

Increased cerebrospinal fluid tau protein in multiple sclerosis

E Kapaki et al.

EUROPEAN NEUROLOGY (2000)